IPO · ANTHEM

Anthem Biosciences IPO listing gain & performance.

Issue price, subscription, listing day and what the share did after, from NSE data. Updated every evening.

· data for the trading session of Wed 18 Nov 2026

Issue price₹570.00₹540 to ₹570
Listing gain+26.9%at the opening price
Since the IPO+60.4%₹914.35 on 18 Nov
Subscribed63.9×times in total

Anthem Biosciences IPO in brief

Written from NSE’s data, as of 18 Nov 2026.

Anthem Biosciences came to the market at ₹570.00 a share (price band ₹540 to ₹570), with bidding open from 14 July to 16 July 2025. It listed on NSE on Monday, 21 July 2025, opening at ₹723.05, a gain of 26.9% on the issue price, and closed the first day +28.1% from the issue price after trading between +26.9% and +31.1%. 65% of the first day’s traded shares were taken for delivery.

The issue was subscribed 63.9× in total, institutions (QIB) 183×, HNIs (NII) 42.4×, retail investors 5.64×. Across the 91 IPOs subscribed 50× or more, the median listing gain was +26.6%.

Its listing gain beat 78% of the 227 main-board IPOs since October 2024, where the median was +7.6%. 1 year after listing it was +38.7% from the issue price and +8.2% from the first-day close, while NIFTY 50 moved -4.4% over the same days. Its highest price so far was 74% above the issue price (9 Nov 2026) and its lowest 2% above it (2 Feb 2026); it closed below the issue price on 0% of the days since listing.

Share price since listing

Daily closes, adjusted for later splits and bonuses. The dashed line is the IPO price.

IPO ₹57021 Jul 202518 Nov 2026₹914

Subscription

Times subscribed by investor group, NSE + BSE bids as reported by NSE.

Qualified institutions (QIB)183×
Non-institutional (NII / HNI)42.4×
NII, bids above ₹10 lakh48.9×
NII, ₹2–10 lakh29.2×
Retail investors5.64×
Employees6.60×
Total63.9×

For comparison, the median main-board IPO since Oct 2024 was subscribed 28.4× in total.

Listing day

Monday 21 July 2025.

Open+26.9%vs issue price
High / low+31% / +27%vs issue price
Close+28.1%vs issue price
Delivery65%₹2,995 Cr traded

Returns after listing

Against the issue price and the first-day close, with NIFTY 50 and the median IPO for comparison.

After listingFrom issue priceFrom first-day closeNIFTY 50Median IPO (from issue)
1 week28 Jul 2025+32.6%+3.5%-1.6%+8.0%
1 month20 Aug 2025+47.5%+15.1%-0.2%+9.4%
3 months21 Oct 2025+30.2%+1.6%+3.1%+10.3%
6 months22 Jan 2026+6.4%-17.0%+0.8%+8.0%
1 year27 Jul 2026+38.7%+8.2%-4.4%-8.9%

IPO details

From NSE’s issue page.

Company
Anthem Biosciences
NSE symbol
ANTHEM
Board
Main board
Industry
Biotechnology
Bidding
14 Jul – 16 Jul 2025
Price band
₹540 to ₹570
Issue price
₹570.00
Issue size
Initial Public Offer of up to Rs. 33,950 million (Including anchor portion of 1,78,24,999 Equity Shares)
Bid lot
26 Equity Shares and in multiples thereof
Listing date
21 July 2025
ISIN
INE0CZ201020

Anthem Biosciences share price, delivery & results →How all IPOs did after listing →IPO calendar →

Questions

What was the listing gain of the Anthem Biosciences IPO?
Anthem Biosciences listed on 21 July 2025 and opened +26.9% against its issue price of ₹570.00; it closed the first day +28.1% from the issue price.
What is the Anthem Biosciences share price now against the IPO price?
At the close of 18 November 2026, Anthem Biosciences was at ₹914.35, +60.4% from the IPO price of ₹570.00.
How many times was the Anthem Biosciences IPO subscribed?
Anthem Biosciences’s IPO was subscribed 63.9× in total; QIB 183×; NII 42.4×; retail 5.64× (NSE + BSE bids, as reported by NSE).
When was the Anthem Biosciences IPO open?
Bidding ran from 14 July to 16 July 2025 at a price band of ₹540 to ₹570; the shares listed on 21 July 2025.

From NSE’s issue list and daily price files (adjusted for later splits and bonuses), and subscription as NSE reports it (NSE + BSE bids). Past IPOs do not predict future ones. Information for learning, not investment advice; ChartMine is not a SEBI-registered adviser.

See it live on your chart.ChartMine for TradingView.